From: Circulating nucleosomes as predictive markers of severe acute pancreatitis
OR | 95 % CI | p value | |
---|---|---|---|
All patients (n = 74) | |||
Univariate analysis | |||
Age (year) | 0.981 | 0.948–1.015 | 0.273 |
Male gender | 10.824 | 1.341–87.370 | 0.025 |
Nucleosomes (AU) | 15.086 | 1.785–127.501 | 0.0127 |
CRP (mg/L) | 1.004 | 1.000–1.008 | 0.045 |
Creatinine (μmol/L) | 1.010 | 1.003–1.017 | 0.005 |
Nucleosomes ≥0.57 AU | 6.316 | 1.127–35.402 | 0.036 |
CRP ≥264 mg/L | 4.500 | 1.283–15.778 | 0.019 |
Creatinine ≥110 μmol/L | 7.615 | 2.239–25.900 | 0.001 |
Multivariate analysis | |||
Male gender | 8.204 | 0.968–69.511 | 0.054 |
Creatinine ≥110 μmol/L | 6.180 | 1.742–21.925 | 0.005 |
Patients with moderately severe or severe acute pancreatitis (n = 51) | |||
Univariate analysis | |||
Age (year) | 0.974 | 0.936–1.014 | 0.207 |
Male gender | 9.684 | 1.110–84.465 | 0.040 |
Nucleosomes (AU) | 5.602 | 0.739–42.474 | 0.095 |
CRP (mg/L) | 1.001 | 0.997–1.005 | 0.579 |
Creatinine (μmol/L) | 1.007 | 1.000–1.013 | 0.052 |
Nucleosomes ≥0.57 AU | 3.289 | 0.575–18.834 | 0.181 |
CRP ≥386 mg/L | 2.364 | 0.201–27.852 | 0.494 |
Creatinine ≥287 μmol/L | 6.842 | 0.738–63.442 | 0.091 |
Multivariate analysis | |||
Male gender | 9.684 | 1.110–84.465 | 0.040 |
Patients with modified marshall score <2 on admission (n = 58) | |||
Univariate analysis | |||
Age (year) | 0.976 | 0.936–1.017 | 0.252 |
Male gender | 6.724 | 0.801–56.432 | 0.079 |
Nucleosomes (AU) | 33.070 | 1.216–899.485 | 0.038 |
CRP (mg/L) | 1.000 | 0.993–1.006 | 0.883 |
Creatinine (μmol/L) | 1.017 | 0.998–1.036 | 0.088 |
Nucleosomes ≥0.39 AU | 5.467 | 1.051–28.432 | 0.043 |
CRP ≥ 227 mg/L | 1.667 | 0.271–10.244 | 0.581 |
Creatinine ≥139 μmol/L | 7.167 | 0.598–85.946 | 0.120 |
Multivariate analysis | |||
Male gender | 6.048 | 0.693–52.799 | 0.104 |
Nucleosomes (AU) | 33.070 | 1.216–899.485 | 0.038 |